Daniel Tereau is President and CEO of Proveris Scientific. Dan brings considerable expertise in life sciences, drug discovery, diagnostics, artificial intelligence, advanced imaging, and scientific instrumentation, with a career focused on translating emerging technologies into meaningful solutions for researchers, pharmaceutical companies, and healthcare organizations.

Prior to joining Proveris, Dan held senior leadership roles at Revvity, Thermo Fisher Scientific, Novartis, and GE Healthcare, where he worked across strategy, innovation, business development, and portfolio transformation. His experience spans drug discovery and development, advanced imaging technologies, laboratory automation, data analytics, and the application of artificial intelligence to scientific workflows.

At Proveris, Dan is focused on advancing the company’s leadership in nasal and orally inhaled drug development, expanding its scientific capabilities, and developing the next generation of technologies and services that help pharmaceutical and biotechnology companies bring innovative medicines to patients more efficiently.

Dan holds an MBA from the Yale School of Management and a Juris Doctor from Wayne State University Law School. He also serves as an adjunct instructor at Brandeis University.